https://doi.org/10.1186/1741-7015-8-74
M
Michael Eichbaum
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
214
Papers
1.5K
Citations
22
h-index
35
i10-index
Michael Eichbaum is an academic researcher. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & PARP inhibition in cancer therapy & BRCA gene mutations in cancer. The author has an h-index of 22, co-authored 182 publications.
ORCID: 0000-0001-5963-3361Papers by this author
worksOne life ends, another begins: Management of a brain-dead pregnant mother-A systematic review-
2010 · BMC Medicine · 106 citations
Learning curve for laparoscopic staging of early and locally advanced cervical and endometrial cancer
2013 · Archives of Gynecology and Obstetrics · 22 citations
https://doi.org/10.1007/s00404-013-2787-y
Circadian rhythm disruption by PARP inhibitors correlates with treatment toxicity in patients with ovarian cancer and is a predictor of side effects
2025 · EBioMedicine · 3 citations
https://doi.org/10.1016/j.ebiom.2025.105764
Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma
2011 · Cancer · 1 citations
https://doi.org/10.1002/cncr.25923
Surgical training in gynecological oncology using soft-embalmed human cadavers: first pilot study
2025 · Archives of Gynecology and Obstetrics · 1 citations
https://doi.org/10.1007/s00404-025-08034-2
Gene Expression And Patient-Reported Outcomes Reveal Links Between Circadian Rhythm Disruption And PARP Inhibitor Toxicity In Ovarian Cancer Patients
2025 · International Journal of Gynecological Cancer · 0 citations
https://doi.org/10.1016/j.ijgc.2024.101460
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat